Increasing 1,25D action by treatment of Hyp mice with 1,25D or FGF23Ab prevents the increase in BMP and IHH and, thus, enthesopathy (14), despite increased Fgf23 mRNA expression in bone and serum FGF23 levels (15). Here, FGF23 is linked to enthesopathy.